These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17000659)

  • 21. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesyl transferase inhibitors.
    Li T; Sparano JA
    Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
    Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
    Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When will we cure cancer?
    Brownlee S
    Time; 1999 Nov; 154(19):80-1, 84. PubMed ID: 10661925
    [No Abstract]   [Full Text] [Related]  

  • 25. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
    Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
    Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenomics and animal models for human individuals].
    Katsuki M
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):902-8. PubMed ID: 10771650
    [No Abstract]   [Full Text] [Related]  

  • 27. Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies.
    Petersen TK; Sørensen P
    Drug Discov Today; 2008 Mar; 13(5-6):240-6. PubMed ID: 18342800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From bedding to bedside: genetically engineered mouse models of cancer inform concurrent clinical trials.
    Damsky WE; Bosenberg M
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):404-5. PubMed ID: 22578163
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer: off by a whisker.
    Dennis C
    Nature; 2006 Aug; 442(7104):739-41. PubMed ID: 16915261
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer researchers usher in dog days of medicine.
    Mack GS
    Nat Med; 2005 Oct; 11(10):1018. PubMed ID: 16211022
    [No Abstract]   [Full Text] [Related]  

  • 31. A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation.
    Clairambault J
    IEEE Eng Med Biol Mag; 2008; 27(1):20-4. PubMed ID: 18270046
    [No Abstract]   [Full Text] [Related]  

  • 32. Realistic rodents? Debate grows over new mouse models of cancer.
    Garber K
    J Natl Cancer Inst; 2006 Sep; 98(17):1176-8. PubMed ID: 16954466
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted therapeutics and implications for pathologists.
    Geyer SJ; Johnson PC
    Am J Clin Pathol; 2002 Jul; 118(1):144; author reply 144. PubMed ID: 12109849
    [No Abstract]   [Full Text] [Related]  

  • 34. 3-D culture in synthetic extracellular matrices: new tissue models for drug toxicology and cancer drug discovery.
    Prestwich GD; Liu Y; Yu B; Shu XZ; Scott A
    Adv Enzyme Regul; 2007; 47():196-207. PubMed ID: 17335875
    [No Abstract]   [Full Text] [Related]  

  • 35. Newer cytotoxic agents: attacking cancer broadly.
    Teicher BA
    Clin Cancer Res; 2008 Mar; 14(6):1610-7. PubMed ID: 18347161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials.
    Degrassi A; Russo M; Scanziani E; Giusti A; Ceruti R; Texido G; Pesenti E
    Prostate; 2007 Mar; 67(4):396-404. PubMed ID: 17187397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular imaging as a tool for personalized and targeted anticancer therapy.
    McLarty K; Reilly RM
    Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeted cancer therapy: promise and reality.
    Klein S; Levitzki A
    Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Man's best friend is also a friend of cancer research.
    Carter A
    J Natl Cancer Inst; 2008 Jul; 100(14):984. PubMed ID: 18612124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.